Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Nathan

Showing results (121-130 of 245) with videos related to

Pageof 25
Sort By:
Diabetes Care|June 25, 2011
Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?Judith C Kuenen, Rikke Borg, Dirk J Kuik, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2014
Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetesFiras H El-Khatib, Steven J Russell, Kendra L Magyar, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 10, 2012
[Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes]Tomoaki Shimizu, David M Nathan, John B Buse, et al.
Annals of Internal Medicine|May 26, 2018
Guidelines Versus Guidelines: What's Best for the Patient?Boris Draznin, David M Nathan, Mary T Korytkowski, et al.
Diabetes Care|February 11, 2012
Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention ProgramAnastassios G Pittas, Jason Nelson, Joanna Mitri, et al.
Diabetes Care|April 24, 2025
The NIDDK Takes on the Complications of Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) StudyBarbara H Braffett, Ionut Bebu, Gayle M Lorenzi, et al.
Annals of Internal Medicine|December 18, 2018
Guidelines Versus GuidelinesBoris Draznin, David M Nathan, Mary T Korytkowski, et al.
The New England Journal of Medicine|February 8, 2002
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metforminWilliam C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, et al.
Diabetes Technology & Therapeutics|December 24, 2025
Differences Between Glycemia Estimates from Hemoglobin A1c and Continuous Glucose Monitoring and Their Association with Complete Blood CountsVeronica Tozzo, David M Nathan, Heidi Krause-Steinrauf, et al.
Journal of General Internal Medicine|January 30, 2004
Health care resource utilization associated with a diabetes center and a general medicine clinicElbert S Huang, Suzanne Gleason, Ronald Gaudette, et al.
Pageof 25

Showing results (121-130 of 245) with videos related to

Sort By:
Pageof 25
Diabetes Care|June 25, 2011
Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients?Judith C Kuenen, Rikke Borg, Dirk J Kuik, et al.
The Journal of Clinical Endocrinology and Metabolism|February 4, 2014
Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetesFiras H El-Khatib, Steven J Russell, Kendra L Magyar, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 10, 2012
[Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes]Tomoaki Shimizu, David M Nathan, John B Buse, et al.
Annals of Internal Medicine|May 26, 2018
Guidelines Versus Guidelines: What's Best for the Patient?Boris Draznin, David M Nathan, Mary T Korytkowski, et al.
Diabetes Care|February 11, 2012
Plasma 25-hydroxyvitamin D and progression to diabetes in patients at risk for diabetes: an ancillary analysis in the Diabetes Prevention ProgramAnastassios G Pittas, Jason Nelson, Joanna Mitri, et al.
Diabetes Care|April 24, 2025
The NIDDK Takes on the Complications of Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) StudyBarbara H Braffett, Ionut Bebu, Gayle M Lorenzi, et al.
Annals of Internal Medicine|December 18, 2018
Guidelines Versus GuidelinesBoris Draznin, David M Nathan, Mary T Korytkowski, et al.
The New England Journal of Medicine|February 8, 2002
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metforminWilliam C Knowler, Elizabeth Barrett-Connor, Sarah E Fowler, et al.
Diabetes Technology & Therapeutics|December 24, 2025
Differences Between Glycemia Estimates from Hemoglobin A1c and Continuous Glucose Monitoring and Their Association with Complete Blood CountsVeronica Tozzo, David M Nathan, Heidi Krause-Steinrauf, et al.
Journal of General Internal Medicine|January 30, 2004
Health care resource utilization associated with a diabetes center and a general medicine clinicElbert S Huang, Suzanne Gleason, Ronald Gaudette, et al.
Pageof 25